Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report.

McDonald VM, Fingleton J, Agusti A, Hiles SA, Clark VL, Holland AE, Marks GB, Bardin PP, Beasley R, Pavord ID, Wark PAB, Gibson PG; participants of the Treatable Traits Down Under International Workshop; Treatable Traits Down Under International Workshop participants:.

Eur Respir J. 2019 May 9;53(5). pii: 1802058. doi: 10.1183/13993003.02058-2018. Print 2019 May. Review.

PMID:
30846468
2.

Health-related quality of life burden in severe asthma.

McDonald VM, Hiles SA, Jones KA, Clark VL, Yorke J.

Med J Aust. 2018 Jul 16;209(S2):S28-S33.

PMID:
30453870
3.

Multidimensional assessment of severe asthma: A systematic review and meta-analysis.

Clark VL, Gibson PG, Genn G, Hiles SA, Pavord ID, McDonald VM.

Respirology. 2017 Oct;22(7):1262-1275. doi: 10.1111/resp.13134. Epub 2017 Aug 3. Review.

4.

Effectiveness of motivational interviewing at improving oral health: a systematic review.

Cascaes AM, Bielemann RM, Clark VL, Barros AJ.

Rev Saude Publica. 2014 Feb;48(1):142-53. Review.

5.

Energy expenditure compared to physical activity measured by accelerometry and self-report in adolescents: a validation study.

Hallal PC, Reichert FF, Clark VL, Cordeira KL, Menezes AM, Eaton S, Ekelund U, Wells JC.

PLoS One. 2013 Nov 4;8(11):e77036. doi: 10.1371/journal.pone.0077036. eCollection 2013.

6.

Predictors of body mass index change from 11 to 15 years of age: the 1993 Pelotas (Brazil) birth cohort study.

Assunção MC, Muniz LC, Dumith SC, Clark VL, Araújo CL, Gonçalves H, Menezes AM, Hallal PC.

J Adolesc Health. 2012 Dec;51(6 Suppl):S65-9. doi: 10.1016/j.jadohealth.2012.08.012. Epub 2012 Nov 10.

7.

Socioeconomic trajectories from birth to adolescence and risk factors for noncommunicable disease: prospective analyses.

Hallal PC, Clark VL, Assunção MC, Araújo CL, Gonçalves H, Menezes AM, Barros FC.

J Adolesc Health. 2012 Dec;51(6 Suppl):S32-7. doi: 10.1016/j.jadohealth.2012.06.022. Epub 2012 Nov 10.

8.

Incidence of school failure according to baseline leisure-time physical activity practice: prospective study.

Rombaldi AJ, Clark VL, Reichert FF, Araújo CL, Assunção MC, Menezes AM, Horta BL, Hallal PC.

J Adolesc Health. 2012 Dec;51(6 Suppl):S22-6. doi: 10.1016/j.jadohealth.2012.06.024. Epub 2012 Aug 29.

9.

Elevated pre-morbid weights in bulimic individuals are usually surpassed post-morbidly: implications for perpetuation of the disorder.

Shaw JA, Herzog DB, Clark VL, Berner LA, Eddy KT, Franko DL, Lowe MR.

Int J Eat Disord. 2012 May;45(4):512-23. doi: 10.1002/eat.20985. Epub 2012 Jan 24.

10.

The role of catalase in gonococcal resistance to peroxynitrite.

Spence SA, Clark VL, Isabella VM.

Microbiology. 2012 Feb;158(Pt 2):560-70. doi: 10.1099/mic.0.053686-0. Epub 2011 Nov 24.

11.

Regulatory and electronic alphabet soup: practice improvements and implications for providers.

Tracy EE, Leffert LR, Clark VL, Ecker J.

Technol Health Care. 2011;19(5):341-7. doi: 10.3233/THC-2011-0640.

PMID:
22027153
12.

Weight suppression predicts time to remission from bulimia nervosa.

Lowe MR, Berner LA, Swanson SA, Clark VL, Eddy KT, Franko DL, Shaw JA, Ross S, Herzog DB.

J Consult Clin Psychol. 2011 Dec;79(6):772-6. doi: 10.1037/a0025714. Epub 2011 Oct 17.

PMID:
22004302
13.
14.

Drug targeting to monocytes and macrophages using esterase-sensitive chemical motifs.

Needham LA, Davidson AH, Bawden LJ, Belfield A, Bone EA, Brotherton DH, Bryant S, Charlton MH, Clark VL, Davies SJ, Donald A, Day FA, Krige D, Legris V, McDermott J, McGovern Y, Owen J, Patel SR, Pintat S, Testar RJ, Wells GM, Moffat D, Drummond AH.

J Pharmacol Exp Ther. 2011 Oct;339(1):132-42. doi: 10.1124/jpet.111.183640. Epub 2011 Jul 21.

PMID:
21778281
15.

Deep sequencing-based analysis of the anaerobic stimulon in Neisseria gonorrhoeae.

Isabella VM, Clark VL.

BMC Genomics. 2011 Jan 20;12:51. doi: 10.1186/1471-2164-12-51.

16.

Design and synthesis of novel pyrimidine hydroxamic acid inhibitors of histone deacetylases.

Donald AD, Clark VL, Patel S, Day FA, Rowlands MG, Wibata J, Stimson L, Hardcastle A, Eccles SA, McNamara D, Needham LA, Raynaud FI, Aherne W, Moffat DF.

Bioorg Med Chem Lett. 2010 Nov 15;20(22):6657-60. doi: 10.1016/j.bmcl.2010.09.016. Epub 2010 Sep 21.

PMID:
20884208
17.

Biochemical and genomic analysis of the denitrification pathway within the genus Neisseria.

Barth KR, Isabella VM, Clark VL.

Microbiology. 2009 Dec;155(Pt 12):4093-103. doi: 10.1099/mic.0.032961-0. Epub 2009 Sep 17.

18.

Nitrite reductase NirS is required for type III secretion system expression and virulence in the human monocyte cell line THP-1 by Pseudomonas aeruginosa.

Van Alst NE, Wellington M, Clark VL, Haidaris CG, Iglewski BH.

Infect Immun. 2009 Oct;77(10):4446-54. doi: 10.1128/IAI.00822-09. Epub 2009 Aug 3.

19.

The use of motivational interviewing techniques to enhance the efficacy of guided self-help behavioral weight loss treatment.

DiMarco ID, Klein DA, Clark VL, Wilson GT.

Eat Behav. 2009 Apr;10(2):134-6. doi: 10.1016/j.eatbeh.2009.02.001. Epub 2009 Feb 15.

PMID:
19447358
20.

Resistance to peroxynitrite in Neisseria gonorrhoeae.

Barth KR, Isabella VM, Wright LF, Clark VL.

Microbiology. 2009 Aug;155(Pt 8):2532-45. doi: 10.1099/mic.0.028092-0. Epub 2009 Apr 30.

21.

Functional analysis of NsrR, a nitric oxide-sensing Rrf2 repressor in Neisseria gonorrhoeae.

Isabella VM, Lapek JD Jr, Kennedy EM, Clark VL.

Mol Microbiol. 2009 Jan;71(1):227-39. doi: 10.1111/j.1365-2958.2008.06522.x.

23.

Laboratory maintenance of Neisseria gonorrhoeae.

Spence JM, Wright L, Clark VL.

Curr Protoc Microbiol. 2008 Feb;Chapter 4:Unit 4A.1. doi: 10.1002/9780471729259.mc04a01s8.

PMID:
18770539
24.

CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells.

Krige D, Needham LA, Bawden LJ, Flores N, Farmer H, Miles LE, Stone E, Callaghan J, Chandler S, Clark VL, Kirwin-Jones P, Legris V, Owen J, Patel T, Wood S, Box G, Laber D, Odedra R, Wright A, Wood LM, Eccles SA, Bone EA, Ayscough A, Drummond AH.

Cancer Res. 2008 Aug 15;68(16):6669-79. doi: 10.1158/0008-5472.CAN-07-6627.

25.

cis- and trans-acting elements involved in regulation of norB (norZ), the gene encoding nitric oxide reductase in Neisseria gonorrhoeae.

Isabella V, Wright LF, Barth K, Spence JM, Grogan S, Genco CA, Clark VL.

Microbiology. 2008 Jan;154(Pt 1):226-39. doi: 10.1099/mic.0.2007/010470-0.

PMID:
18174141
26.

Investment in body image among patients diagnosed with or at risk for malignant melanoma.

Lichtenthal WG, Cruess DG, Clark VL, Ming ME.

Body Image. 2005 Mar;2(1):41-51.

PMID:
18089173
27.
28.

Great expectations: "I'm losing 25% of my weight no matter what you say".

Wadden TA, Womble LG, Sarwer DB, Berkowitz RI, Clark VL, Foster GD.

J Consult Clin Psychol. 2003 Dec;71(6):1084-9.

PMID:
14622084
29.

Frequency and prognosis of emergency coronary artery bypass grafting after percutaneous coronary intervention for acute myocardial infarction.

Moscucci M, O'Donnell M, Share D, Maxwell-Eward A, Kline-Rogers E, De Franco AC, Meengs WL, Clark VL, McGinnity JG, De Gregorio M, Patel K, Eagle KA.

Am J Cardiol. 2003 Oct 15;92(8):967-9.

PMID:
14556874
30.

Diet and physical activity for obesity: how effective are they?

Womble LG, Clark VL, Wadden TA.

J Endocrinol Invest. 2002 Nov;25(10):922-4. Review. No abstract available.

PMID:
12508957
31.

The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions.

Moscucci M, Share D, Kline-Rogers E, O'Donnell M, Maxwell-Eward A, Meengs WL, Clark VL, Kraft P, De Franco AC, Chambers JL, Patel K, McGinnity JG, Eagle KA; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).

J Interv Cardiol. 2002 Oct;15(5):381-6.

32.

Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose.

Freeman RV, O'Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, DeFranco AC, Eagle KA, McGinnity JG, Patel K, Maxwell-Eward A, Bondie D, Moscucci M; Blue Cross-Blue Shield of Michigan Cardiovascular Consortium (BMC2).

Am J Cardiol. 2002 Nov 15;90(10):1068-73.

PMID:
12423705
33.

Spontaneous closure of a perforation-induced coronary artery pseudoaneurysm.

Mikhail B, Brewer RJ, Clark VL.

J Invasive Cardiol. 2002 May;14(5):282-4.

PMID:
11983954
34.

L12 enhances gonococcal transcytosis of polarized Hec1B cells via the lutropin receptor.

Spence JM, Tyler RE, Domaoal RA, Clark VL.

Microb Pathog. 2002 Mar;32(3):117-25.

PMID:
11855942
35.

Identification of transcription activators that regulate gonococcal adaptation from aerobic to anaerobic or oxygen-limited growth.

Lissenden S, Mohan S, Overton T, Regan T, Crooke H, Cardinale JA, Householder TC, Adams P, O'Conner CD, Clark VL, Smith H, Cole JA.

Mol Microbiol. 2000 Aug;37(4):839-55.

36.
37.

Role of ribosomal protein L12 in gonococcal invasion of Hec1B cells.

Spence JM, Clark VL.

Infect Immun. 2000 Sep;68(9):5002-10.

38.

Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial.

Weaver WD, Reisman MA, Griffin JJ, Buller CE, Leimgruber PP, Henry T, D'Haem C, Clark VL, Martin JS, Cohen DJ, Neil N, Every NR.

Lancet. 2000 Jun 24;355(9222):2199-203.

PMID:
10881893
40.
41.
42.

Diffuse pulmonary hemorrhage complicating thrombolytic therapy for acute myocardial infarction.

Gopalakrishnan D, Tioran T, Emanuel C, Clark VL.

Clin Cardiol. 1997 Mar;20(3):298-300.

43.
45.

Risk of cardiac catheterization in patients aged > or = 80 years without previous cardiac surgery.

Clark VL, Khaja F.

Am J Cardiol. 1994 Nov 15;74(10):1076-7. No abstract available.

PMID:
7977055
46.

Concentrated potassium chloride infusions in critically ill patients with hypokalemia.

Kruse JA, Clark VL, Carlson RW, Geheb MA.

J Clin Pharmacol. 1994 Nov;34(11):1077-82.

PMID:
7876399
47.

Unplanned admissions after outpatient cardiac catheterization.

Clark VL, Dolce J.

Clin Cardiol. 1993 Nov;16(11):823-6.

48.

Expression of Porphyromonas gingivalis proteolytic activity in Escherichia coli.

Madden TE, Thompson TM, Clark VL.

Oral Microbiol Immunol. 1992 Dec;7(6):349-56.

PMID:
1338602
49.

Supplemental Content

Loading ...
Support Center